These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35387130)

  • 21. A novel neoantigen discovery approach based on chromatin high order conformation.
    Shi Y; Zhang M; Meng L; Su X; Shang X; Guo Z; Li Q; Lin M; Zou X; Luo Q; Yu Y; Wu Y; Da L; Cai TW; He G; Han ZG
    BMC Med Genomics; 2020 Aug; 13(Suppl 6):62. PubMed ID: 32854726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
    Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
    Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
    Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
    Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy.
    Mauriello A; Zeuli R; Cavalluzzo B; Petrizzo A; Tornesello ML; Buonaguro FM; Ceccarelli M; Tagliamonte M; Buonaguro L
    Cancers (Basel); 2019 Nov; 11(12):. PubMed ID: 31756926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor antigens heterogeneity and immune response-targeting neoantigens in breast cancer.
    Benvenuto M; Focaccetti C; Izzi V; Masuelli L; Modesti A; Bei R
    Semin Cancer Biol; 2021 Jul; 72():65-75. PubMed ID: 31698088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer.
    Zhou J; Zhao W; Wu J; Lu J; Ding Y; Wu S; Wang H; Ding D; Mo F; Zhou Z; Teng L; Chen S
    Biomed Res Int; 2019; 2019():8103142. PubMed ID: 31312661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information.
    Kim S; Kim HS; Kim E; Lee MG; Shin EC; Paik S; Kim S
    Ann Oncol; 2018 Apr; 29(4):1030-1036. PubMed ID: 29360924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation-Derived Neoantigens for Cancer Immunotherapy.
    Castle JC; Uduman M; Pabla S; Stein RB; Buell JS
    Front Immunol; 2019; 10():1856. PubMed ID: 31440245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.
    Qin Y; Ekmekcioglu S; Forget MA; Szekvolgyi L; Hwu P; Grimm EA; Jazaeri AA; Roszik J
    Front Immunol; 2017; 8():689. PubMed ID: 28670312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A proteogenomic approach to target neoantigens in solid tumors.
    Verma A; Halder A; Marathe S; Purwar R; Srivastava S
    Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction.
    Diao K; Chen J; Wu T; Wang X; Wang G; Sun X; Zhao X; Wu C; Wang J; Yao H; Gerarduzzi C; Liu XS
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
    Linette GP; Becker-Hapak M; Skidmore ZL; Baroja ML; Xu C; Hundal J; Spencer DH; Fu W; Cummins C; Robnett M; Kaabinejadian S; Hildebrand WH; Magrini V; Demeter R; Krupnick AS; Griffith OL; Griffith M; Mardis ER; Carreno BM
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23662-23670. PubMed ID: 31685621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapy.
    Zhao W; Wu J; Chen S; Zhou Z
    Pharmacogenomics; 2020 Jun; 21(9):637-645. PubMed ID: 32423288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns.
    Li Z; Chen G; Cai Z; Dong X; He L; Qiu L; Zeng Y; Liu X; Liu J
    Chin J Cancer Res; 2021 Jun; 33(3):364-378. PubMed ID: 34321833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia.
    Zhou W; Yu J; Li Y; Wang K
    Exp Hematol Oncol; 2022 Nov; 11(1):100. PubMed ID: 36384590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neoantigen prediction from genomic and transcriptomic data.
    Battaglia S
    Methods Enzymol; 2020; 635():267-281. PubMed ID: 32122550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-existing heterologous T-cell immunity and neoantigen immunogenicity.
    Leng Q; Tarbe M; Long Q; Wang F
    Clin Transl Immunology; 2020; 9(3):e01111. PubMed ID: 32211191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor neoantigens: from basic research to clinical applications.
    Jiang T; Shi T; Zhang H; Hu J; Song Y; Wei J; Ren S; Zhou C
    J Hematol Oncol; 2019 Sep; 12(1):93. PubMed ID: 31492199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoantigen vaccine: an emerging tumor immunotherapy.
    Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
    Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.